Current knowledge in the field is that AKT activation, M2 macrophage polarity, increased myofibroblast and fibrocytes numbers, and reduced autophagy are observed in the lungs of patients with IPF. The gene discussed is AKT1; the disease is idiopathic pulmonary fibrosis.